Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

David Baldwin, Jr., MD

David Baldwin, Jr., MD
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
Board Certification:
  • Endocrinology, Diabetes & Metabolism
  • Internal Medicine
Faculty Rank: Professor
Medical or Graduate Education: Rush Medical College
Residency: Brigham and Women's Hospital - Internal Medicine
Fellowship: University of Chicago Medical Center - Endocrinology and Metabolism
Clinical Expertise:
  • Acromegaly
  • Addison's disease
  • Adrenal gland cancers
  • Adrenal gland disorders
  • Diabetes
  • Diabetes insipidus
  • Endocrine disorders
  • Fine-needle aspiration biopsy of thyroid
  • Graves' disease
  • Hashimoto's disease
  • Hyperthyroidism
  • Hypoglycemia
  • Hypoparathyroidism
  • Parathyroid disease
  • Pituitary disorders
  • Prolactinoma
  • Thyroid cancer
  • Thyroid disease
Research Interests:
  • Inpatient management of diabetes
  • Posttransplant diabetes
Languages Spoken:
  • English
Google Map
  • Consultants In Endocrinology
  • Professional Building
  • 1725 W. Harrison St.
  • Suite 250
  • Chicago, IL  60612
  • Phone: (312) 942-6163
  • Fax: (312) 563-2096
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. The Association Between Glycemic Control and Clinical Outcomes After the Kidney Transplantation.
    Ramirez SC, Maaske J, Kim Y, Neagu V, Delange S, Mazhari A, Gao W, Emanuele MA, Emanuele N, Baldwin D, Mihailescu DV
    Endocr Pract
    2014 Mar 18
    :1-19.
  2. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.
    Draznin B, Gilden J, Golden SH, Inzucchi SE, , Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Dungan KM, Falciglia M, Figaro MK, Hirsch IB, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Low CC, Wexler DJ
    Diabetes Care
    2013 Jul
    36(7):1807-14.
  3. Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes.
    Baldwin D, Apel J.
    Curr Diab Rep. 2013
    2013 Feb
    13(1):114-20. doi: 10.1007/s11892-012-0339-7.
  4. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.
    Baldwin D, Zander J, Munoz C, Raghu P, DeLange-Hudec S, Lee H, Emanuele MA, Glossop V, Smallwood K, Molitch M.
    Diabetes Care. 2012
    2012 Oct
    35(10):1970-4. Epub 2012 Jun 14.
  5. Insulin in the medical management of postprandial hypoglycemia in a patient with type 2 diabetes after gastric bypass surgery.
    Schoenberger JL, Koh CK, Hor T, Baldwin D, Reddy A, Rondinelli-Hamilton L.
    Case Report Endocrinol. 2012
    2012
    2012:427565. doi: 10.1155/2012/427565. Epub 2012 Jun 28.
  6. Impact of a subcutaneous insulin protocol in the emergency department: Rush Emergency Department Hyperglycemia Intervention (REDHI).
    Munoz C, Villanueva G, Fogg L, Johnson T, Hannold K, Agruss J, Baldwin D.
    J Emerg Med. 2011
    2011 May
    40(5):493-8. doi: 10.1016/j.jemermed.2008.03.017. Epub 2008 Oct 1.
  7. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care.
    Bernard JB, Munoz C, Harper J, Muriello M, Rico E, Baldwin D.
    J Hosp Med. 2011
    2011 May
    6(5):279-84. doi: 10.1002/jhm.866.
  8. Use of U-500 regular insulin via continuous subcutaneous insulin infusion: clinical practice experience.
    Reutrakul S, Brown RL, Koh CK, Hor TK, Baldwin D.
    J Diabetes Sci Technol. 2011
    2011 Jul 1
    5(4):1025-6. No abstract available.
  9. Evaluation of hospital glycemic control at US academic medical centers.
    Boord JB, Greevy RA, Braithwaite SS, Arnold PC, Selig PM, Brake H, Cuny J, Baldwin D.
    J Hosp Med. 2009
    2009 Jan
    4(1):35-44. doi: 10.1002/jhm.390.
  10. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
    Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, Munoz C, Newton C, Peng L, Baldwin D.
    J Clin Endocrinol Metab. 2009
    2009 Feb
    94(2):564-9. doi: 10.1210/jc.2008-1441. Epub 2008 Nov 18.

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612